BriefTea
Every story in sixty words
Get the free app no ads · no paywallHealth · 23 July 2026
Around 5,000 individuals in England stand to gain annually from fampridine, a multiple sclerosis drug described as a "signal booster". Fampridine improves nerve signals, making it easier for some patients to move and live independently. Clinical trials showed about four in ten people taking the drug had better walking speed and could walk for longer.
Reported by BBC · How we write briefs
Understand this story
What is NHS England?More briefs
HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say HealthOver 12,000 fake weight-loss pens worth £2m seized in Birmingham raid WorldUS brain fungus cases quadruple in two years Health82% of therapists say normal emotions are now 'illnesses' More health stories → Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.